REGN Stock — Regeneron Pharmaceuticals Inc.

Regeneron Pharmaceuticals Inc. (REGN)

Updated October 16, 2026.

REGN is a Stock. its distribution rate is 0.48%, its trailing-12-month yield is 0.47%. Dividend Vision Distribution Safety Score™ is 50/100 (Unproven). Total return is 3678.5% over the past 35.5 years.

Regeneron Pharmaceuticals discovers, develops, manufactures, and commercializes medicines for eye diseases, allergies, inflammation, cardiovascular and metabolic conditions, neurological disorders, infectious diseases, and cancer. The company has a low current distribution rate and pays dividends quarterly. Regeneron appeals to growth-oriented investors seeking exposure to the pharmaceutical and biotechnology sector, though it is not primarily positioned as an income stock.

REGN performance

Price and return data through 2026-10-16.

Total return is 3678.5% over the past 35.5 years. Over the past year its total return — price change plus distributions reinvested — is 39.6%. Its deepest 1-year drawdown was 25.9%.

REGN key facts

Distribution Safety Score™

50 · Unproven

Asset type

Stock

Asset class

Equity

Inception date

04/02/1991

Distribution rate

0.48%

Distribution frequency

Quarterly

Trailing yield

0.47%

Last close

$790.74 (as of 2026-10-16)

Market cap

$79,973,737,183

Average volume

653505.0

Dividend

$0.94

Ex-dividend date

08/18/2026

Payment date

08/31/2026

Beta

0.153

Payout ratio

8.2%

P/E ratio

18.92

Forward P/E

14.5138

EPS

$41.80

How Dividend Vision calculates yield and returns

Distribution rate (0.48%) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield (0.47%) is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

REGN risks and drawbacks

REGN's current distribution rate is moderate, not a high-yield payout — the strategy is dividend quality more than maximum income. Payments are quarterly, so cash flow is lumpy versus a monthly fund. The deepest 1-year drawdown on record here is 25.9%.

Who may consider REGN — and who may not

It is a weaker fit for investors who need monthly cash flow (REGN pays quarterly); investors hunting double-digit covered-call yields. This is educational context, not a recommendation to buy or sell.

More on REGN

• All tickers starting with R

Tagged: Dividend.

Frequently asked questions